Compare ICLR & GTLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ICLR | GTLS |
|---|---|---|
| Founded | 1990 | 1859 |
| Country | Ireland | United States |
| Employees | N/A | 11777 |
| Industry | Biotechnology: Commercial Physical & Biological Resarch | Metal Fabrications |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 9.3B | 10.0B |
| IPO Year | 2001 | N/A |
| Metric | ICLR | GTLS |
|---|---|---|
| Price | $167.95 | $209.85 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 13 | 8 |
| Target Price | $178.62 | ★ $205.67 |
| AVG Volume (30 Days) | 955.3K | ★ 1.0M |
| Earning Date | 05-12-2026 | 05-01-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $14.31 |
| Revenue Next Year | N/A | $5.89 |
| P/E Ratio | ★ $12.91 | $240.25 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $66.57 | $163.23 |
| 52 Week High | $211.00 | $209.79 |
| Indicator | ICLR | GTLS |
|---|---|---|
| Relative Strength Index (RSI) | 64.46 | 67.51 |
| Support Level | $154.56 | $206.59 |
| Resistance Level | $193.87 | N/A |
| Average True Range (ATR) | 7.49 | 0.38 |
| MACD | -0.56 | 0.12 |
| Stochastic Oscillator | 68.87 | 90.14 |
Icon is a global contract research organization that provides outsourced clinical development services to pharmaceutical and biotechnology firms. Icon supports clients across late-stage clinical trials through the regulatory approval process and postmarket studies. Icon's services include clinical trial management, patient recruitment, data analytics, laboratory services, and regulatory consulting. With more than 40,000 employees operating in over 50 countries, the company partners with life sciences firms to run clinical trials and bring new drugs to market.
Chart Industries provides a variety of cryogenic equipment for storage, distribution, and other processes within the industrial gas and liquefied natural gas industries. It also provides natural gas processing solutions for the natural gas industry and specialty products that serve a variety of spaces, including hydrogen, biofuels, cannabis, and water treatment. The firm acquired Howden in a significant deal in early 2023, roughly doubling the size of the company. It plans to merge with Flowserve by the end of 2025.